BioSpace News Archive

Pharm Country

InterVenn Presents Results at American Society for Mass Spectrometry Conference

InterVenn Presents Results at American Society for Mass Spectrometry Conference

November 2, 2021
·
2 min read
Drug Development

OncoResponse Announces Initiation of Phase 1 Trial of OR2805 - Human Monoclonal Antibody Derived from Elite Responder to Cancer Immunotherapy - in Patients with Advanced Cancer

OncoResponse today announced initiation of a Phase 1/2 study of OR2805 in patients with advanced cancer. OR2805 is a fully human monoclonal antibody identified from an elite cancer responder

November 2, 2021
·
3 min read
Business

Palleon Pharmaceuticals Appoints David Johnson to Its Board of Directors

Palleon Pharmaceuticals today announced the appointment of David Johnson as an independent director to its Board of Directors.

November 2, 2021
·
2 min read
Biotech Beach

CytRx Highlights Orphazyme’s Update on Productive Meeting with FDA Regarding Arimoclomol in Niemann-Pick Disease Type C

CytRx Corporation today commented on Orphazyme A/S’s (NASDAQ: ORPH) (“Orphazyme”) encouraging regulatory update following its recently held Type A meeting with the U.S. Food and Drug Administration (“FDA”) on arimoclomol

November 2, 2021
·
5 min read
Business

Rebus Biosystems Appoints World-leading Researchers to Scientific Advisory Board

Arul Chinnaiyan and Sten Linnarsson to bolster Rebus expertise and scientific direction

November 2, 2021
·
3 min read
Business

Cyclo Therapeutics Names Preeminent Neuroscientist and World-Renowned Researcher, Cynthia A. Lemere, PhD, as Senior Advisor for Advancement of Alzheimer’s Disease Asset

Cyclo Therapeutics, Inc. today announced the appointment of Cynthia A. Lemere, PhD as Senior Advisor for its Alzheimer’s disease program.

November 2, 2021
·
6 min read
Business

ChemoCentryx to Hold Third Quarter 2021 Financial Results Conference Call on Tuesday, November 9, 2021

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s third quarter 2021 financial results will be released after market close on Tuesday, November 9, 2021.

November 2, 2021
·
1 min read
Pharm Country

Oligomerix Announces Late-Breaking Presentation at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Oligomerix, Inc. announced that the Company will deliver a virtual oral presentation at the 14th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, being held in Boston on November 9-12, 2021.

November 2, 2021
·
2 min read
Biotech Bay

Humanigen Announces Participation and Presentation at Multiple Conferences in November

Humanigen, Inc. announced that management will present and participate at multiple investors conferences in November 2021.

November 2, 2021
·
4 min read
Business

Daewoong’s “Leaps and Bounds” Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters

Sales recorded KRW 290.6 billion, which is up 5% YoY. Operating income and net profit recorded KRW 22.7 billion and KRW 12 billion, respectively, which is up nearly four times YoY.

November 2, 2021
·
2 min read